Skip to main content

Table 2 Fold regulations of the miRNA expressions in premalignant, malignant laryngeal lesions compared to benign lesions C.I. Confidence Interval

From: Comparison of miRNA expressions among benign, premalignant and malignant lesions of the larynx: could they be transformation biomarkers?

Genes

Fold Regulations (compared to benign group)

PREMALIGNANT GROUP

MALIGNANT GROUP

Fold Regulation

p-value

C.I. 95%

Fold Regulation

p-value

C.I. 95%

Hs_miR-375_5p

2.88

0.089235

(0.02, 5.74)

7,22

0.105618

(0.00001, 15.57)

Hs_miR-183_5p

4.16

0.031872

(0.00, 8.32)

12.50

0.020141

(0.00001, 26.86)

Hs_miR-155_5p

2.72

0.027845

(0.55, 4.90)

7.75

0.016086

(0.00001, 15.73)

Hs_let-7a_5p

4.12

0.129245

(0.39, 7.86)

10.55

0.167083

(0.00001, 22.11)

Hs_miR-425_3p

1.14

0.483030

(0.23, 2.05)

5.53

0.097976

(0.00001, 11.12)

Hs_miR-21_5p

3.45

0.066857

(0.01, 6.89)

7.57

0.036338

(0.00001, 16.88)

Hs_miR-218_3p

1.40

0.408852

(0.30, 2.50)

4.45

0.044747

(0.00001, 10.54)

Hs_miR-210_3p

1.86

0.291543

(0.00001, 4.03)

5.98

0.023422

(0.00001, 12.20)

Hs_miR-106b_3p

3.01

0.021868

(0.30, 5.73)

7.31

0.015054

(0.19, 14.44)